ARS Pharma to Present 1 Late-Breaking Oral, 6 Posters at ACAAI
ARS Pharma (Nasdaq: SPRY) will present one late-breaking oral and…
Baylor Genetics to Showcase Clinical and Diagnostic Utility of Genome Sequencing and Multi-omics Across Rare Disease at the American Society of Human Genetics 2025 Annual Meeting
Baylor Genetics Company to share eight poster presentations highlighting advanced diagnostic tools to gain critical insights and shorten…